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Because missense mutations in genetic diseases of membrane proteins often result in endoplasmic reticulum (ER)
retention of functional proteins, drug-induced rescue of their cell surface expression and understanding the underlying
mechanism are of clinical value. To study this, we tested chemical chaperones and sarco(endo)plasmic reticulum Ca2
ATPase pump inhibitors on Madin-Darby canine kidney cells expressing nine ER-retained vasopressin type-2 receptor
(V2R) mutants involved in nephrogenic diabetes insipidus. Of these nine, only V2R-V206D showed improved maturation
and plasma membrane rescue with glycerol, dimethyl sulfoxide (DMSO), thapsigargin/curcumin, and ionomycin but not
with other osmolytes or growth at 27°C. This revealed that rescue is mutant specific and that this mutant is prone to rescue
by multiple compounds. Rescue did not involve changed expression of molecular chaperones calnexin, heat-shock protein
(HSP) 70, or HSP90. V2R antagonist SR121463B treatment revealed that V2R-V206D and V2R-S167T were rescued and
matured to a greater extent, suggesting that the rescuing activity of a pharmacological versus chemical chaperone is
broader and stronger. Calcium measurements showed that rescue of V2R-V206D by thapsigargin, curcumin, and iono-
mycin was because of increased cytosolic calcium level, rather than decreased endoplasmic reticulum calcium level. The
molecular mechanism underlying rescue by DMSO, glycerol, and SR121463B is different, because with these compounds
intracellular calcium levels were unaffected.
INTRODUCTION
In 50% of congenital diseases, such as cystic fibrosis (Skach,
2000), long QT syndrome (Finlayson et al., 2004), or nephro-
genic diabetes insipidus (NDI) (Deen et al., 2000), the under-
lying cause is the presence of missense mutations in the gene
involved. Cell culture expression of the corresponding mu-
tants revealed that the majority of these proteins are mis-
folded and retained by molecular chaperones of the quality
control machinery in the endoplasmic reticulum (ER), after
which they are usually targeted for proteasomal degrada-
tion. Despite the mutation, several studies have reported
that these so-called class II mutants may be functional on a
molecular level, which implicates that compounds that re-
store the routing of such mutants to the cell surface may be
useful as a therapeutic.
A group of compounds known as “chemical chaperones”
is able to facilitate the escape of mutant proteins from the ER
quality control mechanism, leading to their translocation to
the proper subcellular location (Welch and Brown, 1996).
Among these compounds are osmolytes, such as glycerol,
dimethyl sulfoxide (DMSO), and trimethyl-amine-N-oxide
(TMAO) (Sato et al., 1996; Tamarappoo et al., 1999; Yang et
al., 1999; Song and Chuang, 2001) that may facilitate rescue
by stabilizing a mutant protein’s conformation or by induc-
ing a stress response, leading to up-regulation of molecular
chaperones (Welch and Brown, 1996; Diamant et al., 2001).
Also, inhibitors of sarco(endo)plasmic reticulum Ca2
ATPases (SERCAs), such as thapsigargin and curcumin,
have been reported to induce plasma membrane rescue
(Egan et al., 2002; Delisle et al., 2003; Egan et al., 2004).
Because these SERCA pumps help maintaining high endo-
plasmic reticulum calcium level ([Ca2]ER) levels, the inhib-
itors cause decreased ER calcium levels, which are thought
to affect the action of ER molecular chaperones, thereby
allowing mutant proteins to leave the ER (Brostrom and
Brostrom, 2003). Finally, factors that increase expression of
heat-shock proteins (HSPs), such as 4-phenyl butyric acid
(4-PBA) or growth at reduced temperature, are sometimes
able to rescue the cell surface expression of ER-retained
proteins (Choo-Kang and Zeitlin, 2001). Although rescued
cell surface expression has been reported for several chem-
ical chaperones it is still unclear whether rescue is mutation
specific, and whether certain mutants are more prone to be
rescued. In addition, the mechanisms by which chemical
chaperones rescue the cell surface expression of ER-retained
mutants are still largely unknown.
NDI is a disease in which the kidney is unable to concen-
trate urine in response to vasopressin, resulting in polyuria
and polydipsia. The autosomal dominant and recessive in-
heritable forms are caused by mutations in the gene encod-
ing the water channel aquaporin-2, whereas X-linked reces-
sive NDI involves mutations in the vasopressin V2 receptor
(V2R) gene (Deen et al., 2000). Recently, we showed that in
polarized Madin-Darby canine kidney (MDCK) cells, stably
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expressed human V2R coupled to green fluorescent protein
(wtV2R-GFP) is mainly localized in the basolateral mem-
brane and is regulated as can be anticipated to occur in vivo
(Robben et al., 2004). Also, we found that nine V2R missense
mutants in NDI were predominantly retained in the ER
when stably expressed in polarized MDCK cells (Robben et
al., 2005). To address the issues mentioned above, we tested
seven chemical chaperones and incubation at decreased
temperature for their ability to rescue the plasma membrane
expression of these nine V2R mutants. In addition, we set
out to determine the molecular mechanism underlying the
role of cytosolic and ER calcium levels in the rescue of V2R
mutants.
MATERIALS AND METHODS
Materials
Glycerol was from Invitrogen (Carlsbad, CA); DMSO, TMAO, curcumin,
thapsigargin, and probenecid were from Sigma-Aldrich (St. Louis, MO);
4-PBA was from Sigma-Aldrich (Gillingham, United Kingdom); and FURA-
2-acetoxymethyl ester (AM), 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tet-
raacetic acid (BAPTA)-AM, and Pluronic were from Invitrogen (Leiden, The
Netherlands). SR121463B was kindly provided by Dr. C. Serradeil-Le Gal
(Sanofi Synthe´labo, Toulouse, France).
Expression Constructs
Using the QuikChange site-directed mutagenesis kit (Stratagene, Heidelberg,
Germany), mutations were introduced into the human V2R cDNA sequence,
using pEGFP-N1-V2R (Schulein et al., 1998) as a template; the primers GTCG-
CACCTATCTCACGTGGATTGCCCTGATG (V206L), CCGTCGCACATAT-
GAAACCTGGATTGCCCTG (V206E), and CGTCGCACCTACAGAACCTG-
GATTGCCCTG (V206R); and their complementary antisense primers. After
digestion of mutagenized clones with PstI/HindIII, the mutation-containing
fragments were isolated and cloned into the corresponding sites of pEGFP-
N1-V2R. Sequence analysis of selected clones confirmed that only the desired
mutations were introduced.
Cell Culture and Chemical Chaperone Treatments
MDCK type I cells stably expressing the green fluorescent protein (GFP)
tagged wild-type (wt)-V2R or its mutants V2R-L44P, -62-64, -R113W, -I130F,
-S167T, -S167L, -G201D, -T204N, or -V206D were generated and maintained
as described. Stable transfection of MDCK I cells, isolation, analysis, and
selection of clones was performed as described previously (Robben et al., 2004,
2005). For translocation studies, cells were seeded on Costar filters at a density
of 300,000 cells/cm2 and grown for 3 d. Next, cells were treated for 16 h with
4% glycerol, 1% DMSO, TMAO, 5 mM 4-PBA, or 1 M SR121463B at 37°C or
grown for 16 h at 27°C. Alternatively, cells were treated for 2 h at 37°C with
1 M thapsigargin, curcumin, or ionomycin in culture medium unless indi-
cated otherwise.
Immunoblotting and Immunocytochemistry
Poly-acrylamide gel electrophoresis, Western blotting, and immunodetection
were performed as described previously (Deen et al., 2002; Robben et al., 2004).
Immunocytochemistry (ICC), confocal laser scanning microscopy (CLSM),
and data quantification was performed as described previously (Robben et al.,
2005). Mouse anti-HSP70 and -HSP90 antibodies were kindly supplied by Dr.
David Toft (Mayo Clinic, Rochester, MN). Rabbit anti-calnexin antibodies
were kindly supplied by Dr. I. Braakman (UMC Utrecht, Utrecht, The Neth-
erlands)
Calcium Measurements
To measure cytosolic calcium ([Ca2]cyt,) levels, cells were seeded in 35/
22-mm glass bottom dishes (Wilco Wells, Amsterdam, The Netherlands) at a
density of 100,000 cells/cm2 and grown overnight. Subsequently, the cells
were loaded with 3 M FURA-2 in the presence of 100 nM Pluronic and 500
M probenecid in culture medium and incubated for 30 min at 37°C. Because
the phenol red in DMEM interferes with the FURA-2 measurement, measure-
ments were performed in HEPES/Tris buffer. The cells were then washed in
HEPES/Tris buffer (132.6 mM NaCl, 5.8 mM glucose, 10 mM HEPES, 4.2 mM
KCl, and 1 mM MgCl2), followed by addition of 500 M HEPES/Tris buffer
with 500 M probenecid, supplemented with either 1 mM EGTA or different
concentrations of CaCl2 and one of the chemical chaperones. The FURA-2
fluorescence emission ratio at 492 nm was monitored as a measure of
[Ca2]cyt after alternating excitation at 340 and 380 nm using MetaFluor
software (Molecular Devices, Sunnyvale, CA). Averaged data of 25 individual
cells were used per experiment. Measurements were performed on an in-
verted microscope (Axiovert 200 M; Carl Zeiss, Jena, Germany) equipped
with a Zeiss 40/1.3 numerical aperture F Fluar objective coupled to a
CoolSNAP HQ monochrome charge-coupled device camera (Roper Scientific,
Vianen, The Netherlands). Experiments were performed at least in three
times.
RESULTS
Chemical Chaperones and Their Specificity
Recently, we reported that the V2R mutants -L44P, -del62–
64, -I130F, -S167T, -S167L, and -V206D were fully ER re-
tained when stably expressed in polarized MDCK cells,
whereas R113W, -G201D, and -T204N were partially ER
retained (Robben et al., 2005). Consistently, the ER-retained
proteins are expressed as 60- to 63-kDa immature proteins,
whereas the mature forms were expressed as 75-kDa pro-
teins. As the maturation state of the V2R mutants is an
indication for their level of plasma membrane localization,
these mutant-expressing cell lines were incubated with dif-
ferent chemical chaperones and subjected to V2R immuno-
blotting to test for increased receptor maturation. MDCK-
V2R-V206D cells showed an increased amount of mature
V2R when treated with 4% glycerol or 1% DMSO (vol/vol)
for 16 h, or with 1 M thapsigargin for 2 h (Figure 1, top).
Incubation with TMAO, 4-PBA, or growth at 27°C for 16 h
increased the amount of immature V2R proteins, but it did
not induce receptor maturation. For the mutants V2R-S167T
(Figure 1, middle), -L44P, -del62–64, -R113W, -I130F, -S167L,
-G201D, and -T204N (our unpublished data), however, no
significant (p 0.05) increases in maturation were observed.
Immunodetection of -actin revealed equal levels for all
lanes (Figure 1, bottom), which indicated that the cells were
not affected by the given treatments. These effects were
observed for two independent clones per mutant, indicating
that the effects were V2R mutant dependent and not because
of clonal differences. Together, our data show that chemical
chaperones induce maturation of only a limited number of
V2R mutants (i.e., only V2R-V206D) and that the maturation
of this particular mutant can be induced by different chem-
ical chaperones.
Figure 1. Maturation of V2R-V206D upon treatment with chemical
chaperones. Confluent V2R-V206D- or V2R-S167T-expressing
MDCK cells were untreated, incubated for 16 h with 4% glycerol, 1%
DMSO, 1% TMAO, 5 mM 4-PBA or at 27°C, or treated for 2 h with
1 M thapsigargin, lysed in Laemmli sample buffer, loaded on a
10% polyacrylamide gel, and subjected to immunoblotting. V2R-
V206D or -S167T was detected using anti-GFP antibodies (top and
middle, respectively). To ensure equal loading of the samples, blots
were incubated with -actin antibodies (bottom). Duplicate samples
are shown. Mass indications in kilodaltons are given on the left.
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Chemical Chaperones Induce Translocation of V2R-V206D
to the Plasma Membrane
To determine whether chemical chaperones and thapsigar-
gin rescue the cell surface expression of V2R-V206D, cells
grown and treated as described above were subjected to
CLSM, after immunocytochemistry. Colocalizations with the
organelle marker proteins protein disulfide isomerase (PDI)
(ER) and E-cadherin (basolateral membrane) were semi-
quantified using densitometry. As reported previously
(Robben et al., 2005), V2R-V206D in untreated cells is almost
completely localized in the ER (94.5  5.3%; Figure 2A, top),
whereas no V2R-V206D is found in the basolateral mem-
brane. When treated with DMSO (Figure 2A, middle) or
glycerol (our unpublished data), the localization of V2R-
V206D indeed shifted from the ER to the basolateral mem-
brane, because PDI colocalization decreased to 44.2  6.4 or
54.5  7.4%, respectively, whereas E-cadherin colocalization
(our unpublished data) increased to 52.5  7.1 or 49.6 
8.3%, respectively.
On treatment with 1 M thapsigargin for 2 h (Figure 2A,
bottom), localization of V2R-V206D to the ER was reduced
to 46.2  6.5%, whereas the remainder colocalized with
E-cadherin in the basolateral membrane (53.8  7.0%; our
unpublished data). This effect was slightly weaker with 1
M curcumin, because 2-h treatment with this drug de-
creased the ER localization of V2R-V206D to 64.6  7.3%,
whereas its basolateral membrane localization increased to
32.8  6.7% (our unpublished data). Within this time frame,
the rescuing effect with DMSO and glycerol was much
lower. To determine the speed of V2R-V206D rescue by
DMSO and glycerol, we performed a time-response curve,
and semiquantified the corresponding CLSM data (Figure
2B). In time, colocalization with PDI gradually decreases,
which is accompanied with increased colocalization with
E-cadherin. For DMSO, the values obtained for t  8 h were
not significantly (p  0.05) different from the values for t 
16 h described above. For glycerol, however, a significantly
increased rescue effect was observed in this time period (p
0.03).
In all cases, the translocation effect was observed for
	70% of the cells expressing V2R-V206D. The remaining
cells did not show any translocation effect. There was no
correlation between the expression levels of individual cells
and the occurrence of rescue. Also, consistent with the ab-
sence of maturation, none of the other V2R mutants showed
any rescued cell surface expression with any of the chemical
chaperones or thapsigargin (our unpublished data). Incuba-
tion with 2, 4, 6, or 8% DMSO, or with 6, 8, or 10% glycerol,
also induced translocation of V2R-V206D, but semiquantifi-
cation of CLSM data (Figure 2C) revealed that the observed
effect was not significantly increased compared with treat-
ment with 1% DMSO or 4% glycerol. At concentrations
above 10% DMSO or 12% glycerol, the compounds induced
severe morphological changes or showed cytotoxic effects
(as revealed by the reduced number of remaining cells; our
unpublished data).
As shown in Figure 3, no differences in expression were
observed for calnexin, HSP70, or HSP90 between MDCK
cells expressing wtV2R or V2R-V206D. In addition, their
expression was not altered in response to treatment with the
rescue-inducing osmolytes glycerol and DMSO, or with
TMAO.
Chemical Chaperones Versus Cell-permeable Ligands
Recently, Morello et al. (2000) showed that the plasma mem-
brane expression of several, but not all, V2R mutants in
Figure 2. Rescued cell surface expression of V2R-V206D upon treat-
ment with chemical chaperones. (A) MDCK-V2R-V206D cells were
seeded on filters, grown to confluence, and left untreated, or incubated
with 1% DMSO or 1 M thapsigargin (indicated). Cells were subse-
quently fixed and subjected to immunocytochemistry using anti-PDI
antibodies to stain the ER, followed by confocal analysis. Signals for
PDI are shown on the left, whereas signals for the GFP-tagged V2R-
V206D are shown on the right. Bar, 10 m. (B) Confluent MDCK-V2R-
V206D cells were treated for increasing time periods with 1% DMSO or
glycerol (indicated), followed by fixation, immunocytochemical stain-
ing, and confocal analysis as described under A. The percentage of
colocalization of V2R-V206D with E-cadherin (basolateral membrane
marker) or PDI (endoplasmic reticulum marker) was quantified for
each time point (n 3) and plotted as a function of time. (C) Confluent
MDCK-V2R-V206D cells were treated for 16 h with the indicated
concentrations of DMSO (left) or glycerol (right), followed by fixation,
staining, and analysis as described under B. The percentage of colocal-
ization of V2R-V206D with E-cadherin or PDI was quantified for each
concentration (n  3) and plotted.
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human embryonic kidney 293 cells could be rescued by the
cell-permeable V2R antagonist SR121463B (Morello et al.,
2000). To determine whether V2R mutants show a different
sensitivity in rescue toward this pharmacological chaperone
compared with a chemical chaperone, we treated MDCK
cells expressing V2R-V206D or V2R-S167T for 16 h with 1
M SR121463B or 4% glycerol. As shown in Figure 4A,
treatment with SR121463B drastically induced the matura-
tion of both V2R mutants, which coincided with the disap-
pearance of the 60-kDa band. In contrast, glycerol treatment
increases receptor maturation of V2R-V206D only. In line
with these data, immunocytochemistry revealed that,
whereas both mutants localized to the ER when untreated
(Figure 4B, top) and glycerol rescued the plasma membrane
expression of V2R-V206 only (Figure 4B, middle),
SR121463B rescued the basolateral plasma membrane local-
ization of both V2R-V206D and -S167T (Figure 4B, bottom).
These data indicate that SR121463B has a more pronounced
rescuing effect on more V2R mutants than glycerol.
The V206D Mutation Specifically Induces ER Retention
To elucidate whether the ability to restore the plasma mem-
brane localization of V2R-V206D depends on the charge of
the introduced mutation, V206 was changed into a nega-
tively charged glutamic acid (V206E), a hydrophobic leucine
(V206L), or a positively charged arginine (V206R), and sta-
bly expressed in MDCK type I cells. Immunoblot analysis of
expressing clones, however, showed that all these mutants
were mainly expressed as mature 75-kDa proteins (Figure
5A), suggesting that these mutants were hardly ER retained.
Indeed, immunocytochemistry on two clones of each cell
line revealed that V2R-V206E (Figure 5B), V2R-V206R, and
V2R-V206L (our unpublished data) mainly localize in the
basolateral membrane and colocalized only to a minor ex-
tent with PDI. These data indicated that the ER retention of
V2R-V206D is specific for aspartic acid and that no informa-
tion could be obtained on the amino acid specificity of
rescue by chemical chaperones.
Cytosolic Calcium Is Involved in the Rescue of V2R-
V206D
Thapsigargin-induced emptying of ER Ca2 stores, resulting
in decreased free [Ca2]ER, has been postulated to be the
determining factor causing rescue of the F508 mutant of
the cystic fibrosis transmembrane conductance regulator
(CFTR) (Egan et al., 2002). To determine how alterations in
intracellular Ca2 levels affect translocation of V2R-V206D
to the plasma membrane, we determined the changes in
[Ca2]cyt upon drug treatment using the Ca2-sensitive flu-
orophore FURA-2-AM. Addition of thapsigargin to MDCK-
V2R-V206D cells in HEPES/Tris buffer with 2 mM CaCl2
showed a rapid increase of [Ca2]cyt, which peaked after
	30 s, followed by a gradual decrease to a steady-state level
that was slightly increased compared with the starting situ-
ation (Figure 6A). Addition of curcumin showed similar
results, although the peak value and the final plateau phase
were decreased compared with thapsigargin. In Ca2-free
buffer with 1 mM EGTA, base levels of [Ca2]cyt were lower
than in Ca2-containing the buffer, which did not change
with the addition of thapsigargin, except for a small peak
Figure 3. The expression of molecular chaperones is not affected
by osmolyte treatment. MDCK-wtV2R or -V2R-V206D cells were
left untreated or incubated for 16 h with 4% glycerol, 1% DMSO, or
1% TMAO, or 2 h with 1 M thapsigargin or 1 M curcumin
(indicated), lysed, and subjected to immunoblotting as described in
the legend of Figure 1. As primary antibodies, rabbit-anti-GFP (top),
rabbit-anti-calnexin (CNX), mouse-anti-HSP70 (HSP70), or mouse-
anti-HSP90 (HSP90) were used. Per lane, 10 g of total cell lysate
was loaded.
Figure 4. Rescue of V2R mutants by pharmacological and chemi-
cal chaperones. (A) Confluent V2R-V206D- or -S167T-expressing
MDCK cells (indicated) were left untreated or incubated for 16 h
with 4% glycerol, or 1 M SR121463B. Subsequently, cells were
lysed and analyzed by immunoblotting as described in the legends
of Figure 1. (B) V2R-V206D or -S167T expressing MDCK cells (in-
dicated) were seeded on filters, grown to confluence, and subse-
quently left untreated, or incubated for 16 h with 4% glycerol, or 1
M SR121463B. Cells were subsequently fixed and analyzed by
confocal microscopy. Bar, 10 m.
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right after addition, which is likely caused by Ca2 diffusing
from the ER lumen. Supplementary incubation with the
cytosolic Ca2 chelator BAPTA-AM resulted in a low
[Ca2]cyt throughout the experiment.
Immunocytochemistry revealed a similar rescue effect of
V2R-V206D with thapsigargin (Figure 6B, left) and curcumin
in HEPES/Tris buffer with 2 mM Ca2 as in DMEM. With-
out Ca2 and independent of the presence of BAPTA, how-
ever, no V2R-V206D rescue was observed (Figure 6B, right).
These experiments could indicate that increased [Ca2]cyt
instead of reduced [Ca2]ER mediated rescue of V2R-V206D
to the plasma membrane. To further investigate the roles of
[Ca2]ER and [Ca2]cyt in rescue of V2R-V206D, we used the
ionophore ionomycin. This drug renders cell membranes
permeable to Ca2, which allowed us to clamp [Ca2]ER. In
eukaryotic cells, the resting [Ca2]ER is 	300 M Ca2 (Ar-
naudeau et al., 2001; Demaurex and Frieden, 2003). Incuba-
tion of MDCK-V2R-V206D cells in buffer with 2 mM Ca2
did not affect its ER localization (Figure 7, top), but addition
of 1 M ionomycin for 2 h induced a clear translocation of
V2R-V206D to the basolateral membrane (Figure 7, second
top panel). As shown in Figure 7 (third top panel), incuba-
tion of the cells for 2 h with 1 M ionomycin in buffer with
300 M Ca2 also induced a translocation of V2R-V206D to
the basolateral membrane. In Ca2-free buffer with EGTA
and/or BAPTA-AM, however, ionomycin was not able to
rescue the cell surface expression of V2R-V206D (Figure 7,
bottom).
Corresponding FURA-2 measurements showed a steady
state increase in [Ca2]cyt with ionomycin when either 2 mM
or 300 M Ca2, which reached a plateau phase after 	30 s
(Figure 8A). In Ca2-free buffer with 1 mM EGTA, a small
increase in the [Ca2]cyt was observed, which decreased to
below base level after 	2 min. In Ca2-free buffer with
BAPTA-AM and EGTA, [Ca2]cyt again remained low
throughout the experiment.
Several hormones, such as ATP, also induce an increase in
cytosolic calcium via the phospholipase C pathway. To com-
pare the intracellular calcium flux patterns of such a hor-
mone with those induced by thapsigargin, curcumin, and
ionomycin, we added ATP to MDCK cells and measured
intracellular calcium. As shown in Figure 8B, ATP seemed to
induce an increase in intracellular calcium, but with less
total Ca2 mobilization, and different kinetics compared
with the drugs mentioned above. As anticipated, ATP did
not induce a translocation of V2R-V206D to the plasma
membrane (our unpublished data).
DISCUSSION
Rescue of V2R Mutants Is Mutation Specific and Induced
by Several Chemical Chaperones
We have previously shown that in polarized cells, many
V2R mutants involved in the X-linked NDI are retained in
the ER. Out of nine of these mutants, only V2R-V206D
showed a rescued plasma membrane expression and in-
creased receptor maturation upon treatment with chemical
chaperones or calcium-affecting drugs, whereas all other
mutants tested did not (Figures 1 and 2). This illustrates that
plasma membrane rescue is not a general phenomenon for a
particular protein but is specific for a limited set of muta-
tions in a particular protein. This is in line with the results of
Figure 5. V2R-V206L, -V206E, and -V206R are expressed as mature
proteins. (A) MDCK cell lines stably expressing either wild-type
V2R, V2R-V206L, -V206E, -V206R, or -V206D (indicated) were
grown to confluence, lysed, and analyzed by immunoblotting for
GFP. The masses of the immature (60-kDa) and mature (75-kDa)
V2R proteins are indicated on the left. (B) MDCK cells stably ex-
pressing the GFP-tagged V2R-V206E were grown to confluence,
fixed, immunocytochemically stained using anti-PDI and anti-E-
cadherin antibodies, and analyzed by CLSM as described in the
legend of Figure 2. Bar, 10 m.
Figure 6. Cytosolic calcium responses to treatment with SERCA
inhibitors. (A) MDCK type 1 cells were seeded at 100,000 cells/cm2
in glass-bottom culture dishes and grown for 24 h. Cytosolic cal-
cium levels were measured using FURA-2. Cells were incubated in
HEPES/Tris buffer with the indicated levels of Ca2, or EGTA with
or without BAPTA (indicated), to allow the baseline to settle. Thirty
seconds after the start of the measurement (indicated with an ar-
row), 1 M thapsigargin or curcumin (indicated) was added to the
cells followed by measurement of the 340/380-nm ratio. Each data
series comprises the averaged data of 25 cells that were measured
simultaneously. The figures show data of a representative experi-
ment (n 3). (B) Confluent MDCK-V2R-V206D cells were incubated
for 2 h in HEPES/Tris buffer with 1 M thapsigargin, supplemented
with 2 mM Ca2 (left), or 5 mM BAPTA-AM and without Ca2
(right). Subsequently, cells were fixed and analyzed by confocal
microscopy. Bar, 10 M.
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Delisle et al. (2003) who reported that the potassium chan-
nel mutants HERG-G601S and -F805C, found in long QT
syndrome, were rescued in their cell surface expression by
thapsigargin, whereas the localization of HERG-N470D
was not changed. Although we tested only one pharma-
cological chaperone, this class of compounds seems to
induce a stronger level of rescue of V2R mutants, because
the level of maturation of V2R-V206D and V2R-S167T
with SR121463B was better than obtained with the most
optimal concentrations of the chemical chaperones glyc-
erol or DMSO (Figure 4). Moreover, the pharmacological
chaperone seems to act on more V2R mutants than chem-
ical chaperones or SERCA inhibitors, because it also res-
cued the basolateral expression of V2R-S167T. This is in
line with the finding of Morello et al. (2000) who found
that eight of 15 V2R mutants were rescued by SR121463B,
although they used different V2R mutants and did not test
chemical chaperones. In addition to their possible clinical
applicability, this makes cell-permeable antagonists, and
the mechanism by which they facilitate rescue, promising
subjects for more detailed investigation, which will be the
subject of further studies.
The V2R-V206E/R/L mutants were only ER retained to
a minor extent (Figure 4), which may indicate that V206D
is a subtle mutation, thereby allowing proper folding
upon slight structural changes induced by chemical chap-
erones. However, as V2R-R113W, -G201D, and -T204N,
are only partially ER retained (Robben et al., 2005), it is
likely that these mutants are also not severely misfolded.
It is, therefore, striking that the latter three mutants did
not respond to any of the chemical chaperones. Likely, the
relationship between the location and type of a mutation
in the V2R, and the mutant’s ability to be rescued by
chemical chaperones has to await the atomic structure of
the V2R.
Our study furthermore revealed that V2R-V206D cell sur-
face expression is rescued by the chemical chaperones
DMSO and glycerol, the SERCA inhibitors thapsigargin and
curcumin, and the Ca2 ionophore ionomycin, whereas
none of these compounds changed the localization of any of
the other V2R mutants. These data indicate that if a partic-
ular mutant is rescued by one chemical chaperone, it seems
to be more prone to be rescued by others.
Figure 7. Effect of ionomycin and calcium on the localization of
V2R-V206D. Confluent cell layers of MDCK cells stably expressing
GFP-tagged V2R-V206D were incubated for 2 h in HEPES/Tris
buffer with 2 mM Ca2, 2 mM Ca2, and 1 M ionomycin, or 300
M Ca2 and 1 M ionomycin, or in buffer without Ca2 in the
presence of 1 M ionomycin, 5 mM BAPTA-AM, and 1 mM EGTA
(indicated). Subsequently, the cells were fixed, immunocytochemi-
cally stained, and analyzed by CLSM as described in the legend of
Figure 2. Bar, 10 m.
Figure 8. Cytosolic calcium levels in MDCK cells upon treatment
with ionomycin. MDCK cells were grown as described in the legend
of Figure 4. (A) Cells were incubated in HEPES/Tris buffer contain-
ing the indicated levels of Ca2, or EGTA with or without BAPTA
(indicated), to allow the baseline to settle. Thirty seconds after the
start of the measurement (indicated with an arrow), ionomycin was
added to the cells, followed by measurement of the 340/380-nm
ratio. (B) Cells were incubated in HEPES/Tris buffer containing 2
mM Ca2 to allow the baseline to settle. 30 s after the start of the
measurement (indicated with an arrow), 1 M thapsigargin or 10
M ATP (indicated) was added. Each data series comprises the
averaged data of 25 cells that were measured simultaneously. The
figures show data of a representative experiment (n  3).
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Mechanism of Rescue by Chemical Chaperones
Rescue of ER retention of mutant membrane proteins in
eukaryotic cells by osmolytes, such as DMSO and glycerol,
has been postulated to be due to increased expression or
changed functionality of stress-sensitive molecular chaper-
ones (Fuller and Cuthbert, 2000; Choo-Kang and Zeitlin,
2001). Despite rescue of V2R-V206D, however, glycerol and
DMSO treatment did not affect the expression level of the ER
lectin calnexin (Figure 3), which has been suggested to be
involved in ER retention of V2R mutants (Morello et al.,
2001). Also, although increased HSP70 expression levels
have been shown to promote rescue of CFTR-F508 cells
(Choo-Kang and Zeitlin, 2001), its level remained unaltered
with V2R-V206D. In addition, HSP90 expression was un-
changed. Although our data reveal that a changed expres-
sion of these molecular chaperones does not contribute to
V2R-V206D rescue, it does not exclude effects of a changed
activity of these proteins or the involvement of other folding
proteins in this process.
Besides these explanations, DMSO and glycerol have been
suggested to increase the relative hydration around a
polypeptide, thereby inducing a tighter packing of the pro-
tein and a stabilization of the protein’s conformation (Welch
and Brown, 1996; Shearer and Hampton, 2004). However,
although the effects on 3-hydroxy-3-mehtylglutaryl-CoA re-
ductase in yeast are accomplished in minutes, rescue of
V2R-V206D by DMSO and glycerol is only fully effective
after 8–16 h, whereas there is hardly any rescue noticeable
after 2 h (Figure 2B). Although we cannot exclude it, a direct
effect of the osmolytes on V2R-V206D to explain its rescue is
therefore rather unlikely. It remains to be established which
mechanism underlies rescue of V2R-V206D plasma mem-
brane expression by chemical chaperones.
Mechanisms of Rescue by ER Calcium-modifying Drugs
The mechanism underlying rescue by thapsigargin, cur-
cumin, or ionomycin seems to be different in that these
compounds efficiently rescued the cell surface expression of
V2R-V206D within 2 h. Also, these drugs induced a raise in
intracellular calcium levels (Figures 6 and 8), which was not
observed with DMSO, glycerol, or SR121463B (our unpub-
lished data).
Low cytosolic calcium levels are mainly maintained by the
SERCA ATPases, which pump leaked calcium back into the
ER, and by plasma membrane calcium ATPases (PMCAs),
which pump calcium out of the cells. From the combined
FURA-2 measurements and V2R-V206D translocation stud-
ies, the following information can be deduced: First, cells
incubated with thapsigargin, ionomycin, or curcumin in the
absence of extracellular calcium show a small and transient
increase in intracellular calcium in contrast to cells with
extracellular calcium. Cell surface expression of V2R-V206D
is only obtained under the latter condition, which indicates
that an influx of extracellular calcium is needed for the
rescue of V2R-V206D.
Second, if the mechanism by which V2R-V206D is rescued
is identical for thapsigargin, ionomycin, and curcumin, our
data indicate that this is rather because of increased cytoso-
lic, instead of decreased ER calcium levels. Inhibition of
SERCA pumps by thapsigargin, and to a lower extent cur-
cumin, result in a cytosolic calcium spike of 	90 s, which
likely results from an initial extracellular calcium entry and
a reduced ER calcium entry. The following decrease of cy-
tosolic calcium to the observed slightly increased basal lev-
els is likely caused by activated PMCAs. Under this condi-
tion, however, [Ca2]ER will be decreased. The calcium
ionophore ionomycin renders the ER and plasma mem-
branes permeable for calcium (Visch et al., 2004). Under this
condition, PMCAs are not able to compensate the extracel-
lular calcium influx, which is shown by the sustained high
cytosolic calcium levels (Figure 8A). Therefore, [Ca2]cyt and
[Ca2]ER will be similar to the extracellular [Ca2]. Extracel-
lular calcium levels similar (300 M) or well above (2 mM)
ER resting levels coincided with a rescued cell surface ex-
pression of V2R-V206D, which indicated that this rescue was
due to increased [Ca2]cyt levels. The absence of V2R-V206
rescue with ATP indicates that a short transient increase in
cytosolic calcium is not sufficient to mediate rescue. It re-
mains unclear, however, whether the larger calcium peak,
the increased basal calcium level or both are involved in this
rescue.
Because the V206D mutation is exposed to the ER luminal
side, it is unlikely that altered [Ca2]cyt levels directly affect
the mutation. More likely, the observed increased [Ca2]cyt
levels may affect cytosolic folding proteins, such as HSP70 or
HSP90, to facilitate V2R-V206D folding or induce its release
from the ER. If so, this was not mediated by changed ex-
pression levels of these proteins, because these levels were
unchanged (Figure 3). Possibly, the functionality of the
transmembrane ER protein calnexin may be directly or in-
directly affected by changes in [Ca2]cyt, because this mo-
lecular chaperone was shown to have prolonged interaction
with an ER retained V2R mutant compared with wtV2R
(Morello et al., 2001).
Interestingly, thapsigargin and curcumin also rescue the
cell surface expression of CFTR-F508 (Egan et al., 2002,
2004). In contrast to V2R-V206D, however, CFTR-F508 was
rescued in the presence of BAPTA-AM, which indicates that
cytosolic calcium has no role in CFTR-F508 rescue and that
CFTR-F508 rescue is mediated through another mecha-
nism. However, in the experiments of Egan et al. (2002,2004),
a 1-h thapsigargin and BAPTA-AM treatment was followed
by a 1.5-h recovery time. Because thapsigargin, but not
BAPTA-AM, is difficult to wash out, it cannot be excluded
that CFTR-F508 rescue occurred in the last 1.5 h due to
thapsigargin alone. Unfortunately, we were not able to ob-
tain CFTR-F508 or CFTR expression in MDCK cells to test
this further.
In conclusion, we have shown that plasma membrane
rescue by chemical chaperones and altered Ca2 levels only
occurs for V2R-V206D but that its cell surface expression is
rescued by the chemical chaperones glycerol and DMSO. In
addition, the SERCA-inhibitors thapsigargin and curcumin
as well as the Ca2 ionophore ionomycin are able to induce
translocation of V2R-V206D to the plasma membrane by
increasing [Ca2]cyt, rather than by decreasing [Ca2]ER.
Increased insight in the molecular mechanisms that facilitate
restoration of the plasma membrane localization of class II
mutants may aid in developing therapies for diseases caused
by such mutant proteins.
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